Loading…
Saved in:
Source: | Zhongliu Fangzhi Yanjiu, Vol 49, Iss 7, Pp 703-708 (2022) |
---|---|
Publisher Information: | Magazine House of Cancer Research on Prevention and Treatment, 2022. |
Publication Year: | 2022 |
Subject Terms: |
palbociclib, breast cancer, cyclin-dependent kinases 4/6, hormone-receptor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, R
|
Description: |
As the first cyclin-dependent kinases 4 and 6 inhibitors, palbociclib significantly improved the survival of the patients with the hormone r
|
Database: | Directory of Open Access Journals |